Rhythm Pharmaceuticals Inc (RYTM) — Quality & forensics
As of 2026-10-07 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 5
- Quality 21
- Growth 71
- Balance sheet 60
- Cash quality 64
- Capital allocation 8
- Momentum 38
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the RYTM chart & overview · the earnings record
FAQ · from the current data · as of 2026-10-07
Quick answers
What is Rhythm Pharmaceuticals Inc's Closelooknet quality reading?
The composite reads 39/100 across 7 modules, as of 2026-10-07: valuation 5, quality 21, growth 71, balance sheet 60, cash quality 64, capital allocation 8, momentum 38. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Rhythm Pharmaceuticals Inc's Altman Z-Score?
14.40, which sits in the safe zone (above 2.99) as of 2026-10-07. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Rhythm Pharmaceuticals Inc's Piotroski F-Score?
5 of 8, as of 2026-10-07. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Rhythm Pharmaceuticals Inc's Beneish M-Score indicate?
-2.88 — below the −1.78 manipulation-risk threshold, as of 2026-10-07. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- ONC BeiGene, Ltd.industry
- PTGX Protagonist Therapeutics Incindustry
- REGN Regeneron Pharmaceuticals Incindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- CORT Corcept Therapeutics Incorporatedindustry
- MRNA Moderna Incindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- DNA Ginkgo Bioworks Holdingsindustry
- RXRX Recursion Pharmaceuticals Incindustry
- IBRX Immunitybio Incindustry
- GMAB Genmab ASindustry
- TWST Twist Bioscience Corpindustry
- HALO Halozyme Therapeutics Incindustry
- EXEL Exelixis Incindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- BANB.SW Bachem Holding AGindustry
- APGE APGE.USindustry
- ARGX.BR Argen-Xindustry
- TECH Bio-Techne Corpindustry